Comment

Journal of the American Statistical Association

Volumn 92, Issue 440, 1997, Pages 1248-1250

  Gelman, Andrew ^a   Bois, Frederic Y ^b  

^a Howard Hughes Medical Institute   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011222719     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1080/01621459.1997.10473644     Document Type: Article

References (11)

1. Bois, F. Y, Gelman, A., Jiang, J., Maszle, D., and Alexeef, G.(1996), "Population Toxicokinetics of Tetrachloroethylene," Archives of Toxicology,70, 347-355.
2. Gelman, A., Bois, F. Y, and Jiang, J.(1996), "Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions" Journal of the American Statistical Association, 91, 1400-1412.
3. Gelman, A., Meng, X. L., and Stem, H.S. (1996), "Posterior Predictive Assessment of Model Fitness via Realized Discrepancies" (with discussion), Statistica Sinica, 6, 733-807.
4. Hayball, P. J., Wrobel, J., Tamblyn, J. G., and Nation, R. L.(1994), "The Pharmacokinetics of Ketorolac Enantiomers Following intramuscular Administration of the Racemate,"British Journal of Clinical Phannacology, 37, 75-78.
5. Jallad, N. S., Garg, D. C., Martinez, J. J., Mroszczak, E. J., and Weidler, D. J. (1990), "Pharmacokinetics of Single-Dose Oral and Intramuscular Ketorolac Tromethamine in the Young and Elderly,"Journal of Clinical Pharmacology, 30, 76-81.
6. Jung, D., Mroszczak, E., and Bynum, L.(1988), "Pharmacokinetics of Ketorolac Tromethamine in Humans after Intravenous, Intramuscular and Oral Administration,"European Journal of Clinical Pharmacology,35, 423-425.
7. Jung, D., Mroszczak, E. J., Wu, A., Ling, T. L., Sevelius, H., and Bynum, L.(1989), "Pharmacokinetics of Ketorolac and phydroxyketorolac Following Oral and Intramuscular Administration of Ketorolac Tromethamine,"Pharmaceutical Research, 6, 62-65.
8. Lucker, P., Bullingham, R., Hooftman, L., Lloyd, J., and Mroszczak, E.(1994), ''Tolerability, Central Effects and Pharmacokinetics of Intravenous Ketorolac Tromethamine in Volunteers,"International Journal of Clinical Pharmacology and Therapeutics, 32,409-414.
9. Ten Have, T. R., Pulkstenis, E., Kunselman, A., and Landis, J. R.(1997), "Mixed Effects Logistic Regression Models for Longitudinal Binary Response Data With Informative Dropout," technical report, Pennsylvania State University, Dept. of Biostatistics.
10. Vakily, M., Corrigan, B., and Jamali, F.(1995), "The Problem of Racemization in the Stereospecific Assay and Pharmacokinetic Evaluation of Ketorolac in Humans and Rats,"Pharmaceutical Research, 12, 1652-1657.
11. Wakefield, J. C.(1996), ''The Bayesian Analysis of Population Pharmacokinetic Models,"Journal of the American Statistical Association, 91,917-927.